CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sorin SpA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sorin SpA
Via Benigno Crespi n. 17
Phone: +39 0269969711p:+39 0269969711 MILANO, 20159  Italy Ticker: SRNSRN

This company was Merged or Acquired on 10/19/2015.
This is a Subsidiary, click here for the Parent Company

Business Summary
Sorin SpA is an Italy-based group active in the field of medical technology for the treatment of cardiovascular diseases. It focuses on three business units. The Cardiopulmonary (CP) unit develops, manufactures and markets disposable biomedical devices and systems, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories, and systems for autotransfusion and autologous blood washing. The Heart Valves (HV) unit develops, manufactures and markets implantable prostheses to replace or repair heart valves, including tissue and mechanical heart valves, as well annuloplasty rings. The Cardiac Rhythm Management (CRM) unit focuses on production of pacemakers to reestablish normal cardiac rhythm, implantable cardiac defibrillators, cardiac resynchronization therapy (CRT) systems to treat heart failure and monitor the risk of arrhythmia. In January 2014, Banca Monte dei Paschi di Siena sold entire shareholding in Sorin SpA, equal to approximately 5.7%.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201512/31/2014Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board RosarioBifulco 67 12/30/2008 12/30/2008
President, Heart Valves Business Unit DavideBianchi
President, Cardiopulmonary Business Unit & Intercontinental MichelDarnaud
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Alcard Industria Mecanica Ltda
California Medical Laboratories, Inc.
Gish Biomedical, Inc.
Neurotech SA
Sorin Group USA, Inc.
SRN

General Information
Number of Employees: 3,940 (As of 6/30/2015)
Outstanding Shares: 477,188,557 (As of 6/30/2015)
Stock Exchange: BIT
Fax Number: +39 0269969777


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023